Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-12
2010-10-12
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S375000, C514S406000, C514S408000, C548S125000, C548S221000, C548S374100, C548S578000
Reexamination Certificate
active
07812040
ABSTRACT:
This invention is directed to a compound of the formula Ia or Ib, as defined herein, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition containing a compound of formula I, a method of treatment of a disorder or condition that may be treated by antagonizing histamine H3 receptors, the method comprising administering to a mammal in need of such treatment a compound of formula I as described above, and a method of treatment of a disorder or condition selected from the group consisting of depression, mood disorders, schizophrenia, anxiety disorders, Alzheimer's disease, attention-deficit disorder (ADD), attention-deficit hyperactivity disorder (ADHD), psychotic disorders, sleep disorders, obesity, dizziness, epilepsy, motion sickness, respiratory diseases, allergy, allergy-induced airway responses, allergic rhinitis, nasal congestion, allergic congestion, congestion, hypotension, cardiovascular disease, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastro-intestinal tract, the method comprising administering to a mammal in need of such treatment a compound of formula I as described above.
REFERENCES:
patent: 2005/0171181 (2005-08-01), Wager et al.
patent: WO 02072570 (2002-09-01), None
patent: WO 2004101546 (2004-11-01), None
Bianchi Kristin
Kispert Jennifer A.
Pfizer Inc.
Ronau Robert T.
Saeed Kamal A
LandOfFree
Histamine-3 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Histamine-3 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Histamine-3 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4192939